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Abstract
Background: Induction of general anesthesia with propofol and fentanyl is frequently associated with changes in arterial blood pressure and heart rate. 
At present, there are no clinical studies investigating the relation between baseline cardiac autonomic tonus and cardiovascular instability after induction 
of general anesthesia with propofol and fentanyl.
Material and methods: A randomized prospective study was performed with approval of Ethic Committee. Written informed consent was obtained 
from all patients. We enrolled in the study 47 ASA physical status I–II patients scheduled for elective surgical procedures. Heart rate variability by Holter 
ECG, arterial blood pressure (systolic, diastolic, mean), and heart rate were measured at baseline, after premedication, as well as after induction of general 
anesthesia with propofol 2.5mg/kg and fentanyl 1.0 mkg/kg.
Results: our research revealed that increased baseline cardiac parasympathetic tonus was a risk factor for development of sinus bradycardia (OR = 21.0 
(95%CI 3.9-112.8, p<0.0002) and sinus bradycardia associated with arterial hypotension (OR = 19.2 (95%CI 4.1-88.6, p<0.0001).
Conclusions: Induction of general anesthesia with propofol and fentanyl was associated frequently with arterial hypotension and sinus bradycardia. 
Increased cardiac parasympathetic tonus at rest represents a risk factor for development of arterial hypotension and sinus bradycardia after administration 
of propofol and fentanyl for induction of general anesthesia.
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Introduction
Propofol is a frequently used hypnotic for sedation as 
well as for induction of general anesthesia. But, when this 
drug is injected rapidly it can lead to hemodynamic insta-
bility, mainly to arterial hypotension and changes in heart 
rhythm. Both, sinus tachycardia and sinus bradycardia were 
reported after administration of propofol for sedation or for 
induction of general anesthesia [1-3]. Many mechanisms 
have been involved for explanation of propofol induced 
arterial hypotension, mainly direct depression of myocar-
dium, reduced peripheral vascular resistance caused by di-
rect vasodilatory effect of the drug, reduction of preload and 
afterload. The studies anyway, showed controversial results, 
and any of these factors could be imputed for hemodynamic 
instability after administration of propofol for sedation or 
for induction of general anesthesia [2-7]. Administration of 
propofol for moderate or deep sedation is frequently associ-
ated with a significant decrease in mean blood pressure. This 
hypotensive effect of the drug can be caused by reduction of 
sympathetic cardiac tonus or disturbances in baroreceptor-
mediated cardiac activity [4-6]. Similar to other intravenous 
anesthetic agents like benzodiazepines and barbiturates, 
propofol exerts its hypnotic actions by activation of the cen-
tral inhibitory neurotransmitter – gamma-aminobutyric 
acid (GABA) [7].
Most often propofol administration is combined with 
opioid (fentanyl or sufentanyl).  This combination has a 
beneficial effect as can reduce the requirement in myorelax-
ants in the course of general anesthesia. But, on the other 
hand the combination between propofol and opioid can en-
hance the risk for arterial hypotension and bradycardia in 
patients [8,9]
Heart rate variability (HRV) is a noninvasive electro-
cardiographic marker which reflects the sympathetic and 
parasympathetic influences on sinus node of the heart. In 
other words, HRV analysis shows the baseline autonomic 
function of the heart. Measurements of HRV are noninva-
sive, and highly reproducible. They may be performed on 
the basis of 24 hour Holter recordings or on shorter periods 
ranging from 0.5 to 5 minutes particularly in the field of dy-
namic electrocardiography. Most studies in anesthesia and 
intensive care which used the HRV for analysis of changes 
in sympathetic-parasympathetic balance of the heart per-
formed the 5 minutes analysis of HRV [10,11]. 
The purpose of this clinical research was to find a re-
lationship between autonomic heart tonus at rest and the 
risk for development of arterial hypotension and changes in 
heart rate after induction of general anesthesia with propo-
fol and fentanyl.
7
8I. Feghiu. Moldovan Medical Journal. June 2019;62(3):7-12 ORIGINAL  ReseARch
Material and methods
We performed a prospective randomized study to evalu-
ate the relationship between baseline cardiac autonomic to-
nus of the heart and the risk for development of cardiovas-
cular instability after induction of general anesthesia with 
fentanyl and propofol. The study protocol was approved by 
the Ethic Committee of the State University of Medicine 
and Pharmacy “Nicolae Testemiţanu”, Chișinău (No.20, 
2.02.2016). 
Between March 2017 and September 2017, ASA physi-
cal status I-II patients aged less than 60 years (to exclude 
age-related changes of HRV) scheduled for elective surger-
ies with normal sinus rhythm on ECG were enrolled in the 
study. We obtained an informed consent from all research 
participants. Patients with diseases that could affect auto-
nomic cardiac regulation (endocrine, neurological, cardio-
vascular diseases) were excluded from the study. 
In the operating room, the patients were monitored 
(Holter ECG (Holter TLC 5000, USA)), non-invasive blood 
pressure, pulse oximetry and capnography). Baseline heart 
rate (HR), systolic blood pressure (SBP), diastolic blood 
pressure (DBP), and respiratory rate were recorded. During 
induction of general anesthesia, oxygen was delivered to 
maintain SpO2 above 95%. All patients received 10 ml/kg of 
crystalloid before induction of anaesthesia. 
HRV parameters, HR, SBP, DBP and respiratory rate 
were recorded at baseline (T1), 5 minutes after premedica-
tion with Fentanyl 1.0 mkg/kg (T2) and 5 minutes after in-
duction of general anesthesia with propofol 2.5 mg/kg and 
fentanyl 1.0 mkg/kg (T3). If after receiving propofol and 
fentanyl, patients developed bradypnea or apnea, the mask 
ventilation was initiated at a rate of 14-16 breaths/min and 
tidal volume of 7-8 ml/kg, an important requirement for 
correct registration and analysis of HRV.
HRV parameters were analyzed by Holter computer-
ized system. HRV was interpreted according to the rec-
ommendations of the Task Force of the European Society of 
Cardiology and the North American Society of Pacing and 
Electrophysiology [12]. In this clinical study HRV was used 
for assessment of autonomic heart tonus at rest.
Sinus tachycardia was considered in any patient who had 
a heart rate more than 100 beats/min, and sinus bradycardia 
– a heart rate less than 60 beats/min.
We considered systolic arterial hypertension when SBP 
was more than 140 mmHg or an increase in SBP of more 
than 20% from baseline values, systolic arterial hypotension 
– when SBP was less than 90 mmHg or a decrease in SBP 
more than 20% below baseline, and diastolic hypotension 
– when DBP was less than 60 mmHg or a decrease in DBP 
more than 20% below baseline.
Statistical analysis of the results was performed using 
GraphPad Prism 6 (GraphPad Software, San Diego, 
California, SUA). Values with parametric distribution were 
analyzed by t-pair and repeated measures ANOVA tests. 
Values with non-parametric distribution were analyzed by 
Wilcoxon and Friedman tests. The Fisher’s exact test was 
used to compare categorical variables. Results are expressed 
as 95% confidence interval of odd ratio (parametric data) 
and median with interquartile range (IQR, non-parametric 
data). A p value of less than 0.05 was considered statistically 
significant. 
Results and discussion
The study group consisted of 47 patients (26 females and 
21 males), aged 37.5±11.9 years. The mean body mass index 
was 24.6±3.4 kg/m2 (it ranged between 16.1 and 30.0 kg/m2). 
Holter heart rate variability analysis revealed that in 
baseline 38.3% of patients were with enhanced sympathetic 
tonus of the heart and 38.3% – with enhanced parasympa-
thetic tonus of the heart. Another 23.4% of patients present-
ed with heart eutonia (fig. 1).
Fig. 1.  Structure of the study group in function of vegetative 
tonus of the heart at rest.
There were no significant changes in SBP, DBP, MAP 
and HR after premedication with fentanyl (1.0 mkg/kg), 
but after induction of general anesthesia with propofol 
2.5 mkg/kg and fentanyl 1.0 mkg/kg, SBP decreased by 
Table 1
Changes in blood pressure and heart rate after premedication and induction of general anesthesia
Parameters T1 T2 T3 p
SBP 138.9
(134.0-143.7)
133.9
(129.6-138.1)
99.7
(95.9-103.5)
0.001
DBP 85.4*
(81.5-89.2)
79.0*
(75.5-82.5)
51.1*
(48.6-53.5)
0.001
MAP 103.1*
(98.9-107.3)
97.7 *
(94.1-101.3)
67.9*`
(65.5-70.4)
0.001
HR 73.1
(69.9-76.4)
72.8
(69.4-76.1)
61.4
(59.1-63.6)
0.001
*Blood pressure and HR values are represented as mean and 95%CI or as median and interquartile range for data with nonparametric distribution.
I. Feghiu. Moldovan Medical Journal. June 2019;62(3):7-12ORIGINAL  ReseARch
25.5% (from 133.9 mmHg at T2 to 99.7 mmHg at T3; 
p=0.001), DBP – decreased by 35.5% (from 79.0 mmHg 
at T2 to 51.1 mmHg at T3; p<0.001), MAP – decreased 
by 30.5% (from 97.7 mmHg at T2 to 67.9 mmHg at T3; 
p<0.001), and  HR – decreased by 15.7% (from 72.8 beats/
min at T2 to 61.4 beats/min at T3; p<0.001), (tab. 1). 
After induction of general anesthesia with propofol and 
fentanyl most patients developed systolic-diastolic or dia-
stolic hypotension (41 patients – 87.2%) and sinus brady-
cardia (24 patients – 51.1%) (fig. 2, fig. 4). More frequently 
there was attested diastolic hypotension (35 patients – 
74.5%), only in 6 patients (12.8%) there was found systolic-
diastolic hypotension. Minimal SBP was 69.0 mmHg, mini-
mal DBP was 37.0 mmHg and minimal registered MAP was 
49.0 mmHg. More frequently systolic-diastolic hypoten-
sion or diastolic hypotension was registered at 3-5 minutes 
(4.6±0.3 min) after administration of propofol and fentanyl. 
Arterial hypotension was corrected with fluids, and none 
of the patients required vasopressor support. In the study 
group only in 3 patients (6.4%) was found arterial hyperten-
sion. It is worth mentioning the fact that in all these patients 
arterial hypertension was present only the first 1-3 minutes 
(1.1±0.6 min) after administration of propofol and fentanyl. 
Maximal SBP was 169.0 mmHg, maximal DBP was 109.0 
mmHg, and maximal registered MAP was 134.0 mmHg. All 
these 3 patients who developed arterial hypertension after 
induction of general anesthesia presented enhanced sympa-
thetic tonus of the heart at rest.
Fig. 2.  The number of patients with normal BP, arterial 
hypertension and arterial hypotension at rest, after 
premedication and induction of general anesthesia.
It is important to remark the fact that out of 41 patients 
who developed arterial hypotension after induction of gen-
eral anesthesia, in 18 patients (43.9%) was attested enhanced 
parasympathetic tonus of the heart at rest. Holter ECG 
analysis revealed that all 18 patients with enhanced cardiac 
parasympathetic tonus in baseline developed arterial hypo-
tension after administration of propofol and fentanyl. Other 
15 patients (36.6%) who developed arterial hypotension 
were with enhanced sympathetic tonus of the heart at rest, 
and 8 patients (19.5%) – with heart eutonia at rest.
Fisher’s exact test of the relation between presence of en-
hanced parasympathetic tonus of the heart at rest and the 
risk for development of arterial hypotension after admin-
istration of propofol and fentanyl for induction of general 
anesthesia revealed: Odds ratio – 10.2 (95%CI 0.54-19.8)
(p=0.06), with sensitivity – 1.0 (95%CI 0.8-1.0), specificity – 
0.2 (95%CI 0.08-0.39). Even if, OR and sensitivity are high, 
specificity is reduced, such enhanced parasympathetic to-
nus of the heart in baseline doesn’t represent a risk factor for 
development of arterial hypotension after administration of 
propofol and fentanyl (fig. 3).
After administration of propofol and fentanyl for induc-
tion of general anesthesia there were found changes of HR 
on ECG.  Most patients (51.1%) developed sinus bradycar-
dia (fig. 4). Minimal HR registered by Holter ECG was 43/
min. Minimal HR was registered at 3-5 minutes (4.1±0.6 
min) after injection of propofol and fentanyl. Sinus tachy-
cardia was registered in 3 patients (6.4%) from the study 
group. All these 3 patients presented enhanced sympathetic 
tonus of the heart at rest. Maximal HR registered by ECG 
Holter was 116/min, and was attested most frequently at 
2.1±0.6 min after administration of propofol and fentanyl.
Fig. 4.  The number of patients with normal HR, sinus 
tachycardia and sinus bradycardia at rest, after premedication 
and induction of general anesthesia.
It is worth mentioning that most patients (66.6%) who 
developed sinus bradycardia after administration of propo-
fol and fentanyl had increased parasympathetic heart tonus 
at rest.  Sixteen of the 18 patients with enhanced baseline 
parasympathetic tonus of the heart developed sinus brady-
cardia after administration of fentanyl and propofol. On the 
other hand, only 4 of the 18 patients with enhanced basal 
sympathetic cardiac tonus, and 4 of the 11 patients with 
heart eutonia at rest developed sinus bradycardia after in-
duction of general anesthesia.
It can therefore be concluded that enhanced baseline 
parasympathetic tonus of the heart is a risk factor for devel-
opment of sinus bradycardia after administration of propo-
fol and fentanyl:
Fig. 3.  Relation between autonomic cardiac tonus at rest and 
development of arterial hypotension after induction of general 
anesthesia with propofol and fentanyl.
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Odds Ratio – 21.0 (95%CI 3.9-112.8; p<0.0002); sensibility 
0.89 (95%CI 0.65-0.99) and specificity 0.72 (95%CI 0.53-
0.87) (fig. 5).
In 21 patients from the study group (44.7%) after injec-
tion of propofol and fentanyl was attested arterial hypoten-
sion associated with sinus bradycardia. It is important to 
mention the fact that Holter ECG analysis revelead that out 
of these 21 patients in 15 (71.4%) was attested enhanced 
parasimpathetic cardiac tonus at rest. On the other hand, 
only 2 of the 18 patients with enhanced baseline sympathe-
tic cardiac tonus, and 4 of the 11 patients with heart eutonia 
at rest developed sinus bradycardia associated with arterial 
hypotension after induction of general anesthesia.
Fisher’s exact test of the relation between cardiac auto-
nomic tonus at rest and the risc for development of arte-
rial hypotension associated with sinus bradycardia revealed: 
Odds Ratio – 19.2 (95%CI 4.1–88.6; p<0.0001); sensitivity – 
0.83 (95%CI 0.58-0.96) and specificity – 0.79 (95%CI 0.60-
0.92) (fig. 6 ). It can therefore be concluded that enhanced 
parasympathetic tonus of the heart at rest is a risk factor for 
development of sinus bradycardia associated with arterial 
hypotension after administration of propofol and fentanyl 
for induction of general anesthesia. 
Fig. 6.  Relation between autonomic cardiac tonus at rest and 
development of arterial hypotension associated with sinus 
bradycardia after induction of general anesthesia
Discussion
Propofol is an intravenous hypnotic agent, which com-
monly is used for anesthesia induction due to rapid onset, 
short duration of action, anti-nausea and vomiting effect 
and feeling comfortable after surgery. The most promi-
nent effect of propofol is a decrease in arterial blood pres-
sure during induction of anesthesia and is associated with 
a decrease in cardiac output, stroke volume, and systemic 
vascular resistance. Furthermore, propofol induces severe 
vasodilation while the effects of myocardial depression are 
not exactly clear. Vasodilation occurs in both venous and 
arterial circulation, which leads to reduced preload and af-
terload [1, 5, 7, 13, 14].
Although there are many studies that evaluated the effect 
of propofol and fentanyl on cardiac autonomic nervous sys-
tem using heart rate variability [2-6], the relation between 
cardiac autonomic tonus at rest and the risk for cardiovas-
cular instability after induction of anesthesia with propofol 
and fentanyl have not been investigated before.
In the literature there are published several studies which 
compare the hemodynamic effects of propofol with other 
hypnotic drugs, most often from the group of barbiturates 
or benzodiazepines.
In a study by Frolich M.A. et al. which involved 60 
healthy volunteers ASA I physical status, subjects received 
4 dose level ranges of propofol to provide anxyolitic level to 
moderate sedative effect. Predicted propofol concentrations 
in this study were 0.1, 0.2, 0.4 and 0.8 mkg/kg. A signifi-
cant dose dependent blood pressure reduction was in the 
propofol group compared to midazolam group. Significant 
decreases in blood pressure were at propofol concentration 
0.4 and 0.8 mkg/kg [13].
In another prospective, double-blinded, randomized 
clinical study by Kilic E. et al., proved that combination of 
alfentanil (10.0 mkg/kg) with propofol 0.7 mg/kg for seda-
tion in upper gastrointestinal system endoscopy in morbid-
ly obese patient is more frequently combined with bradycar-
dia and arterial hypotension than combination of propofol 
with ketamine [8]. Chidambaran V. et al. conducted a study 
to evaluate total intravenous anesthesia with propofol and 
fentanyl in obese children and adolescents (aged 9-18 years) 
during laparoscopic surgery. Propofol was administered at 
a standardized infusion rate of 1000 μg/kg/min combined 
with fentanyl 50-100 μg. In all patients were attested hemo-
dynamic changes and drop in SBP, DBP and MAP was more 
than 20% from the baseline value [9].
In a recent study, aiming to compare the effect of the 
ketamine-propofol mixture (ketofol) and propofol on the 
insertion conditions of laryngeal mask airway and hemo-
dynamic stability in pediatrics patient (age ranging from 
2 to 15 years) physical status ASA I and II, and undergo-
ing elective surgical procedures, Aberra B. et al., proved a 
significant decrease in blood pressure and heart rate in the 
group of patients who received propofol (3.5 mg/kg) com-
pared with the group of patients who received a mixture of 
propofol and ketamine [14].  Soleimani A. et al. proved that 
induction of general anesthesia in patients with left ven-
tricular dysfunction with diazepam is safer than induction 
with propofol in term of hemodynamics. In this study in the 
group of patients who received propofol (1.5 mg/kg) after 
premedication with fentanyl (2.0 µg/kg) the decrease in SBP, 
DBP and MAP was significantly grater than in the group of 
Fig. 5.  Relation between autonomic cardiac tonus at rest and 
development of sinus bradycardia after induction of general 
anesthesia.
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patients who received midazolam or etomidate for induc-
tion of general anesthesia [15]. Another group of authors 
[16], compared the hemodynamic effects of propofol with 
the hemodynamic effects of etomidate when used for induc-
tion of general anesthesia in patients undergoing coronary 
artery bypass grafting /mitral valve and aortic valve replace-
ment surgery. In this study all patients received fentanyl 2.0 
mkg/kg 3 minutes prior to induction. The dose of propofol 
for induction of general anesthesia was 2.0 mg/kg. There 
was significant decrease in SBP, DBP and MAP between the 
groups after induction, after intubation and 5 min postintu-
bation. There was significant decrease in cardiac output and 
cardiac index in propofol group when compared to baseline 
values after induction, after intubation and 5 minutes after 
intubation, but not in etomidate group.
There are several studies which compare the hemody-
namic effects of propofol used for sedation in patients un-
dergoing gastrointestinal endoscopy [17-19]. In a prospec-
tive, randomized, double-blind study by Usman S. et al. [17] 
was compared the hemodynamic effects of propofol (1.0 
mg/kg propofol followed by repeated doses of 10 to 20 mg 
propofol intravenously) with that of midazolam associated 
with meperidine (0.4 mg/kg meperidine intravenously fol-
lowed three minutes later by 0.05 mg/kg midazolam intra-
venously) in 100 patients scheduled for diagnostic upper 
gastrointestinal endoscopy. The authors observed signifi-
cantly more adverse cardiopulmonary events with propo-
fol compared to meperidine/midazolam (20% vs. 4%, p = 
0.025). Hypotension incidence was significantly higher in 
the propofol group compared to the meperidine/midazol-
am group (12% vs. 0%, p=0.027). In this study, the authors 
found that midazolam/meperidine is superior to propofol 
with respect to the occurrence of adverse cardiopulmonary 
events, particularly hypotension. Tsai H. C. et al. performed 
a meta-analysis of randomized clinical trials aiming to com-
pare the efficacy and safety of propofol and midazolam for 
sedation in cirrhotic patients undergoing endoscopy. Five 
studies between 2003 and 2012, including 433 patients, were 
included. In four of the selected randomized clinical trials 
arterial hypotension was more frequently in the patients 
who receive propofol than in patients who receive midazol-
am. In three of the selected studies was evaluated the inci-
dence of bradycardia based on a heart rate (HR) < 55 beats 
per minute. The incidence of bradycardia was 6% (9/150) 
in the propofol group and 2.86% (4/140) in the midazolam 
group [18]. In another recent meta-analysis conducted to 
compare the efficacy and safety of midazolam and propofol 
in gastrointestinal endoscopy five randomized controlled 
trials involving 552 patients were included [19]. The con-
clusion of this meta-analysis was that propofol sedation for 
gastrointestinal endoscopy results in higher endoscopist 
satisfaction scores, but may increase the incidence of hypo-
tension and bradycardia.
Another study examined the safety and effectiveness of 
the procedural sedation analgesia technique carried out in 
the emergency department. The research was done to com-
pare the effectiveness and efficacy of moderate sedation of 
fentanyl (0.1 mkg/kg) combined with propofol (1.0 mg/
kg) or midazolam (1.0 mg/kg). None of the patients in ei-
ther group developed any adverse events during and after 
the procedures. No significant drops in blood pressure and 
heart rate were observed during and after the procedures. 
Even though a few parameters, such as MAP, SBP and DBP, 
dropped intra-procedure, these values normalized post-
procedure, and the changes were statistically insignificant 
within and between the groups [20].
Most studies which analyze the hemodynamic effects 
of propofol alone or propofol associated with opioid (as in 
this study) proved that a drop in SBP, DBP, MAP and HR 
can develop. These hemodynamic changes can be present 
even after administration of propofol and fentanyl in dos-
es lower than in this study. However, there is not a single 
clinical research which studied the relation between base-
line cardiac autonomic tonus of the heart and the risk for 
development of arterial hypotension and changes of heart 
rate after administration of propofol and fentanyl for in-
duction of general anesthesia. This study revealed that en-
hanced baseline cardiac parasympathetic tonus represents 
a risk factor for development of sinus bradycardia and ar-
terial hypotension associated with sinus bradycardia after 
administration of propofol and fentanyl for induction of 
general anesthesia.
Conclusions
1. Induction of general anesthesia with propofol and fen-
tanyl is frequently associated with arterial hypotension and 
sinus bradycardia. 
2. Enhanced parasympathetic tonus of the heart at rest is 
a risk factor for development of sinus bradycardia and sinus 
bradycardia associated with arterial hypotension after injec-
tion of propofol and fentanyl.
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